This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wong, C.-M. Articles by Ng, I. O.-l. Search for Related Content PubMed PubMed Citation Articles by Wong, C.-M. Articles by Ng, I. O.-l.

Genetic and Epigenetic Alterations of DLC-1 Gene in Hepatocellular Carcinoma

¹ Departments of Pathology
² Biochemistry, the University of Hong Kong, Hong Kong, People’s Republic of China

Hepatocellular carcinoma (HCC) is one of the most common fatal cancers in the world. However, the underlying molecular mechanisms contributing to hepatocarcinogenesis are still unclear. A putative tumor suppressor gene, namely DLC-1 (frequently deleted in liver cancer) was identified and mapped at chromosome 8p21.3–22, a recurrently deleted region in human cancers. The gene exerts inhibitory effects on the cell proliferation of HCC cells. In this study, we investigated the biological function, and genetic and epigenetic status of this gene in human HCC. With in vitro GTPase activating proteins activity assay, we established that DLC-1 protein was a GTPase-activating protein specific for RhoA and Cdc42. Deletion of the DLC-1 gene was frequent in human HCC, as revealed by loss of heterozygosity analysis performed on 100 human HCC cases with markers mapped at the DLC-1 locus, and allelic losses ranging from 44% to 50% of the informative cases. However, somatic mutations of the DLC-1 gene were rare. Moreover, with real-time quantitative PCR, we found that DLC-1 mRNA was significantly underexpressed in HCCs when compared with the corresponding nontumorous livers (P < 0.0001). In addition, the CpG island 5' to the DLC-1 gene was methylated in 3 of 7 HCC cell lines and in 6 (24%) of 25 primary HCCs. These data suggest that transcriptional silencing by hypermethylation may contribute to the inactivation of the DLC-1 gene. Taken together, the results of our study suggest that both genetic and epigenetic alterations play an important role in inactivation of the DLC-1 gene in hepatocarcinogenesis.

This article has been cited by other articles:

				P. Erlmann, S. Schmid, F. A. Horenkamp, M. Geyer, T. G. Pomorski, and M. A. Olayioye DLC1 Activation Requires Lipid Interaction through a Polybasic Region Preceding the RhoGAP Domain Mol. Biol. Cell, October 15, 2009; 20(20): 4400 - 4411. [Abstract] [Full Text] [PDF]

				K. Kawai, Y. Iwamae, M. Yamaga, M. Kiyota, H. Ishii, H. Hirata, Y. Homma, and H. Yagisawa Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells, February 1, 2009; 14(2): 227 - 241. [Abstract] [Full Text] [PDF]

				R.-P. Scholz, J. Regner, A. Theil, P. Erlmann, G. Holeiter, R. Jahne, S. Schmid, A. Hausser, and M. A. Olayioye DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling J. Cell Sci., January 1, 2009; 122(1): 92 - 102. [Abstract] [Full Text] [PDF]

				T. Y. Kim, K. D. Healy, C. J. Der, N. Sciaky, Y.-J. Bang, and R. L. Juliano Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration J. Biol. Chem., November 21, 2008; 283(47): 32762 - 32770. [Abstract] [Full Text] [PDF]

				G. Holeiter, J. Heering, P. Erlmann, S. Schmid, R. Jahne, and M. A. Olayioye Deleted in Liver Cancer 1 Controls Cell Migration through a Dia1-Dependent Signaling Pathway Cancer Res., November 1, 2008; 68(21): 8743 - 8751. [Abstract] [Full Text] [PDF]

				W. Xue, A. Krasnitz, R. Lucito, R. Sordella, L. VanAelst, C. Cordon-Cardo, S. Singer, F. Kuehnel, M. Wigler, S. Powers, et al. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma Genes & Dev., June 1, 2008; 22(11): 1439 - 1444. [Abstract] [Full Text] [PDF]

				J.-Z. Pang, L.-X. Qin, N. Ren, Z.-Y. Hei, Q.-H. Ye, W.-D. Jia, B.-S. Sun, G.-L. Lin, D.-Y. Liu, Y.-K. Liu, et al. Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7363 - 7369. [Abstract] [Full Text] [PDF]

				L. Fu, Y.-R. Qin, D. Xie, L. Hu, D. L. Kwong, G. Srivastava, S. W. Tsao, and X.-Y. Guan Characterization of a Novel Tumor-Suppressor Gene PLC{delta}1 at 3p22 in Esophageal Squamous Cell Carcinoma Cancer Res., November 15, 2007; 67(22): 10720 - 10726. [Abstract] [Full Text] [PDF]

				Y.-C. Liao, L. Si, R. W. deVere White, and S. H. Lo The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1 J. Cell Biol., January 1, 2007; 176(1): 43 - 49. [Abstract] [Full Text] [PDF]

				H. Shi, J. Guo, D. J. Duff, F. Rahmatpanah, R. Chitima-Matsiga, M. Al-Kuhlani, K. H. Taylor, O. Sjahputera, M. Andreski, J. E. Wooldridge, et al. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma Carcinogenesis, January 1, 2007; 28(1): 60 - 70. [Abstract] [Full Text] [PDF]

				S. Simoes, B. Denholm, D. Azevedo, S. Sotillos, P. Martin, H. Skaer, J. C.-G. Hombria, and A. Jacinto Compartmentalisation of Rho regulators directs cell invagination during tissue morphogenesis Development, November 1, 2006; 133(21): 4257 - 4267. [Abstract] [Full Text] [PDF]

				Y-F Song, R Xu, X-H Zhang, B-B Chen, Q Chen, Y-M Chen, and Y Xie High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma J. Clin. Pathol., September 1, 2006; 59(9): 947 - 951. [Abstract] [Full Text] [PDF]

				M. Guan, X. Zhou, N. Soulitzis, D. A. Spandidos, and N. C. Popescu Aberrant Methylation and Deacetylation of Deleted in Liver Cancer-1 Gene in Prostate Cancer: Potential Clinical Applications Clin. Cancer Res., March 1, 2006; 12(5): 1412 - 1419. [Abstract] [Full Text] [PDF]

				G. Yu, G. C. Tseng, Y. P. Yu, T. Gavel, J. Nelson, A. Wells, G. Michalopoulos, D. Kokkinakis, and J.-H. Luo CSR1 Suppresses Tumor Growth and Metastasis of Prostate Cancer Am. J. Pathol., February 1, 2006; 168(2): 597 - 607. [Abstract] [Full Text] [PDF]

				T. H.-Y. Leung, Y.-P. Ching, J. W. P. Yam, C.-M. Wong, T.-O. Yau, D.-Y. Jin, and I. O.-L. Ng Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity PNAS, October 18, 2005; 102(42): 15207 - 15212. [Abstract] [Full Text] [PDF]

				C.-M. Wong, J. W.-P. Yam, Y.-P. Ching, T.-O. Yau, T. H.-Y. Leung, D.-Y. Jin, and I. O.-L. Ng Rho GTPase-Activating Protein Deleted in Liver Cancer Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma Cancer Res., October 1, 2005; 65(19): 8861 - 8868. [Abstract] [Full Text] [PDF]

				S. Goodison, J. Yuan, D. Sloan, R. Kim, C. Li, N. C. Popescu, and V. Urquidi The RhoGAP Protein DLC-1 Functions as a Metastasis Suppressor in Breast Cancer Cells Cancer Res., July 15, 2005; 65(14): 6042 - 6053. [Abstract] [Full Text] [PDF]

				F. Alpy and C. Tomasetto Give lipids a START: the StAR-related lipid transfer (START) domain in mammals J. Cell Sci., July 1, 2005; 118(13): 2791 - 2801. [Abstract] [Full Text] [PDF]

				J. Adams, S. V. Williams, J. S. Aveyard, and M. A. Knowles Loss of Heterozygosity Analysis and DNA Copy Number Measurement on 8p in Bladder Cancer Reveals Two Mechanisms of Allelic Loss Cancer Res., January 1, 2005; 65(1): 66 - 75. [Abstract] [Full Text] [PDF]

				Y. Kim, R. C. Sills, and C. D. Houle Overview of the Molecular Biology of Hepatocellular Neoplasms and Hepatoblastomas of the Mouse Liver Toxicol Pathol, January 1, 2005; 33(1): 175 - 180. [Abstract] [Full Text] [PDF]